Jianing Tang

804 total citations
24 papers, 476 citations indexed

About

Jianing Tang is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Jianing Tang has authored 24 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Cell Biology and 5 papers in Oncology. Recurrent topics in Jianing Tang's work include Ubiquitin and proteasome pathways (13 papers), RNA modifications and cancer (6 papers) and Hippo pathway signaling and YAP/TAZ (6 papers). Jianing Tang is often cited by papers focused on Ubiquitin and proteasome pathways (13 papers), RNA modifications and cancer (6 papers) and Hippo pathway signaling and YAP/TAZ (6 papers). Jianing Tang collaborates with scholars based in China, Saudi Arabia and United States. Jianing Tang's co-authors include Ledu Zhou, Guo Long, Gaosong Wu, Xiao Liang, Zelin Tian, Yongwen Luo, Xing Liao, Yongguang Tao, Desheng Xiao and Qiuxia Cui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Cell Death and Differentiation.

In The Last Decade

Jianing Tang

22 papers receiving 474 citations

Peers

Jianing Tang

PRM

ONCOL

Junyi Ju China

Arun M. Unni United States

Julius Semenas Sweden

Anil Narasimha United States

Barbara Antoniani Italy

Ranran Kong China

Yun Seong Jeong United States

Pier‐Luc Clermont Canada

Timothy J. Stanek United States

Junyi Ju China

Jianing Tang

441 ×1.1

217 ×1.7

72 ×0.6

PRM

95 ×0.8

ONCOL

53 ×0.8

Citations per year, relative to Jianing Tang Jianing Tang (= 1×) peers Junyi Ju

Countries citing papers authored by Jianing Tang

Since Specialization

Citations

This map shows the geographic impact of Jianing Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianing Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianing Tang more than expected).

Fields of papers citing papers by Jianing Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianing Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianing Tang. The network helps show where Jianing Tang may publish in the future.

Co-authorship network of co-authors of Jianing Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Jianing Tang. A scholar is included among the top collaborators of Jianing Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianing Tang. Jianing Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Long, Guo, Yilin Pan, Yulin Xie, et al.. (2025). Deubiquitylating Enzymes in Hepatocellular Carcinoma. International Journal of Biological Sciences. 21(9). 4270–4292.

Cao, Jing, Kui Chen, Kuan Hu, et al.. (2025). USP2-mediated PPARγ stabilization promotes hepatocellular carcinoma progression and M2 macrophage polarization via oleic acid. Journal for ImmunoTherapy of Cancer. 13(11). e012721–e012721.

Zhou, Yanling, Fang Cheng, Xin Peng, et al.. (2024). Histones Methyltransferase NSD3 Inhibits Lung Adenocarcinoma Glycolysis Through Interacting with PPP1CB to Decrease STAT3 Signaling Pathway. Advanced Science. 11(38). e2400381–e2400381. 7 indexed citations

Tang, Jianing, Guo Long, Kuan Hu, et al.. (2023). Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. Advanced Science. 10(33). e2302953–e2302953. 65 indexed citations

Tang, Jianing, Qian Yang, Chao Mao, et al.. (2023). The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway. Cell Death and Differentiation. 30(5). 1247–1259. 36 indexed citations

Long, Guo, et al.. (2023). UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells. Free Radical Biology and Medicine. 212. 162–173. 13 indexed citations

Tang, Jianing, Guo Long, Desheng Xiao, et al.. (2023). ATR‐dependent ubiquitin‐specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistance. SHILAP Revista de lepidopterología. 4(6). e463–e463. 16 indexed citations

Ou, Zhenyu, Peihua Liu, Zhao Cheng, et al.. (2023). ATXN3 promotes prostate cancer progression by stabilizing YAP. Cell Communication and Signaling. 21(1). 152–152. 11 indexed citations

Tang, Jianing, Guo Long, Xiao Liang, & Ledu Zhou. (2023). USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through β-catenin stabilization. Cell Death and Disease. 14(6). 360–360. 53 indexed citations

10.

Long, Guo, Dong Wang, Jianing Tang, & Weifeng Tang. (2023). Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma. Aging. 5 indexed citations

11.

Tang, Jianing, et al.. (2023). The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis. Cell Communication and Signaling. 21(1). 198–198. 16 indexed citations

12.

Wang, Xiaobo, et al.. (2022). Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer. Cancer Science. 114(5). 2041–2052. 5 indexed citations

13.

Tang, Jianing, et al.. (2022). USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ. Cell Death and Disease. 13(4). 326–326. 19 indexed citations

14.

Zhou, Yanling, Liang Xiao, Guo Long, et al.. (2022). Identification of senescence-related subtypes, establishment of a prognosis model, and characterization of a tumor microenvironment infiltration in breast cancer. Frontiers in Immunology. 13. 921182–921182. 11 indexed citations

15.

Tang, Jianing, Yongwen Luo, Guo Long, & Ledu Zhou. (2021). MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α. Cell Death and Disease. 12(10). 937–937. 23 indexed citations

16.

Tang, Jianing, Yongwen Luo, Zelin Tian, et al.. (2020). TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α. Neoplasia. 22(9). 343–351. 41 indexed citations

17.

Cui, Qiuxia, Dan Zhang, Deguang Kong, et al.. (2020). Co-transplantation with adipose-derived cells to improve parathyroid transplantation in a mice model. Stem Cell Research & Therapy. 11(1). 200–200. 8 indexed citations

18.

Tang, Jianing, Zelin Tian, Xing Liao, & Gaosong Wu. (2020). SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer. International Journal of Biological Sciences. 17(2). 417–429. 31 indexed citations

19.

Tang, Jianing, Jiangbo Ren, Qiuxia Cui, et al.. (2019). A prognostic 10‐lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients. Journal of Cellular and Molecular Medicine. 23(10). 6775–6784. 16 indexed citations

20.

Tian, Zelin, Jianing Tang, Qian Yang, et al.. (2019). Atypical ubiquitin-binding protein SHARPIN promotes breast cancer progression. Biomedicine & Pharmacotherapy. 119. 109414–109414. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact